^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

COMPANY:
Minomic

i
Other names: Minomic | MINOMIC | Minomic International Ltd
Related tests:
Evidence

News

8ms
New peer-reviewed paper on MiCheck Prostate (Minomic Press Release)
"Minomic...announce the publication of the company’s latest research paper supporting the utilisation of MiCheck Prostate as an aid to diagnosing clinically significant prostate cancer."
Clinical data
|
MiCheck® Prostate
9ms
Minomic International Ltd receives reimbursement for MiCheck Prostate in the USA (Minomic Press Release)
"Minomic International Ltd...announce that the company’s ground-breaking test for prostate cancer, MiCheck Prostate, has received its first reimbursement in the United States from the Centres for Medicare and Medicaid Services (CMS)."
Medicare • Reimbursement
|
MiCheck® Prostate
10ms
Minomic’s presentation at the 23rd Asia-Pacific prostate cancer conference (Minomic Press Release)
"We are proud to be presenting at the 23rd Asia-Pacific Prostate Cancer Conference, one of the largest comprehensive prostate cancer meetings in the world, that is being held between 18 – 20 August 2023 in Cairns...Minomic CEO, Dr Brad Walsh will present a poster 'Performance of MiCheck Prostate in Patients with a Prior Prostate Biopsy'. The performance data will also be presented in a rapid-fire talk on Saturday 19 August at 1pm in the trade display area."
Clinical data
|
MiCheck® Prostate
over1year
Australian diagnostics company Minomic records breakthrough commercial sale in the US (Minomic Press Release)
"Australian diagnostics company Minomic International Ltd (Minomic) is pleased to announce that their lead product, MiCheck® Prostate, has recorded its initial commercial sales in the US, the world’s largest healthcare market...The MiCheck® Prostate test is run at Minomic Inc’s CLIA Certified 'High Complexity' Laboratory located in Gaithersburg, Maryland. The test has become available following CLIA Laboratory registration and internal validation of MiCheck® Prostate in 2022. The first tests have already been ordered by Las Vegas Urology, a large urology practice based in Nevada."
Sales
|
MiCheck® Prostate
almost2years
Sydney Biotech Minomic International Ltd strikes new arrangement to make MiCheck® Prostate test available for Australians (Minomic Press Release)
"Minomic International Ltd has taken a step forward to bring the MiCheck® Prostate test to Australians...With testing available now at selected Sonic Healthcare Australia Pathology laboratories, Minomic can offer MiCheck® Prostate to many more Australian men."
Licensing / partnership
|
MiCheck® Prostate
2years
Minomic International Ltd celebrates US lab partnership at ribbon cutting event (Minomic Press Release)
"Minomic CEO Dr Brad Walsh and US Commercialisation Lead Megan Henken presented at its US lab partner 20/20 GeneSystems’ ribbon cutting event in Rockville, Maryland last week to celebrate the commencement of CLIAx’s operations...Minomic signed an agreement with 20/20 GeneSystems’ CLIAx team to provide lab services essential to bringing to market its MiCheck® Prostate test that is designed to detect aggressive prostate cancer."
Licensing / partnership
|
MiCheck® Prostate
2years
Minomic granted CLIA certification enabling commercial launch of MiCheck® prostate in the US (Minomic Press Release)
"Minomic International Limited is pleased to announce that its wholly owned subsidiary, Minomic Inc., has been granted a Clinical Laboratory Improvement Amendments (CLIA) certification, allowing its lab to officially open for business, in Gaithersburg, MD...The CLIA program regulates laboratories that perform testing on patient specimens in order to ensure accurate and reliable test results. CLIA enables the release of test results following the laboratory demonstrating certain quality assurance characteristics relating to analytical validity for the use of that test system in the laboratory’s own environment."
Regulatory
|
MiCheck® Prostate